Logo

SEC filing

Sophia Genetics Increases IPO Target to $221M

The company will now offer 13 million common shares at $17 to $19 per share, raising its proceeds target from the previously announced $100 million.

Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare

Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.

Progenity Raises $40M in Private Placement

The firm said it will use the funds to support its operations, to invest in its molecular testing research and development program, and for working capital.

SeqLL Withdraws Plans for $8M IPO

The Massachusetts sequencing firm has been selling technology originally developed by Helicos BioSciences and planned to increase marketing with the IPO proceeds.

Grail Raises $125M in Equity Financing Offering

The firm plans to raise as much as $250 million, according to the document filed with the US Securities and Exchange Commission.

Breaking News
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.